Patent · US Active

Processes and intermediates for preparing a Btk inhibitor

US12215110B2 · kind B2 · utility

0Cited by

1References

22Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Philip Pye · Guttenberg, US
Andras Horvath · Turnhout, BE
Cheng-Yi Chen · Burnaby, CA
Yuanyuan YUAN · Changzhou City, CN
Jinxiong Su · Changzhou City, CN
Shuo-En Wang · Changzhou City, CN
Simon Albert Wagschal · Schaffhausen, CH

Key dates

Filing date	May 20, 2020
Grant date	Feb 4, 2025
Priority date	—
Expiry date	Apr 1, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a process for the preparation of certain intermediates, e.g. a process for preparing a compound of formula (I) wherein, R1, R2 and X1 are as defined in the description, and which intermediate and processes are useful in the preparation of a BTK inhibitor, such as ibrutinib.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.